NASDAQ: SANA - Sana Biotechnology, Inc.

Rentabilité sur six mois: -52.56%
Secteur: Healthcare

Calendrier des promotions Sana Biotechnology, Inc.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise

Sana Biotechnology, Inc., биотехнологическая компания, специализируется на использовании искусственных клеток в качестве лекарств. Компания разрабатывает платформы клеточной инженерии in vivo и ex vivo для различных терапевтических областей с неудовлетворенными потребностями в лечении, включая онкологию, диабет, расстройства центральной нервной системы, сердечно-сосудистые заболевания, генетические нарушения и другие. Sana Biotechnology, Inc. ранее была известна как FD Therapeutics, Inc. и сменила свое название на Sana Biotechnology, Inc. в сентябре 2018 года.

Plus de détails
Компания была зарегистрирована в 2018 году со штаб-квартирой в Сиэтле, штат Вашингтон.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

EV/EBITDA 0.2284
EBITDA -0.1393
Цена ао 5.71
Сайт https://www.sana.com
P/BV 3.47
Число акций ао 0.19454 млрд
Див.доход ао 0
ISIN US7995661045
Валюта usd
IPO date 2021-02-04
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Changement de prix par jour: +4.18% (3.83)
Changement de prix par semaine: -5.67% (4.23)
Changement de prix par mois: -11.92% (4.53)
Changement de prix sur 3 mois: -32.94% (5.95)
Changement de prix sur six mois: -52.56% (8.41)
Changement de prix par an: +24.69% (3.2)
Evolution du prix sur 3 ans: -78.28% (18.37)
Evolution des prix depuis le début de l'année: -6.56% (4.27)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 0 0
P/BV 3.08 5
P/E 0 0
EV/EBITDA -2.89 0
Total: 3.13

Efficacité

Nom Signification Grade
ROA, % -50.11 0
ROE, % -98.52 0
Total: 0

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA -0.3529 10
Total: 9.4

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 0 0
Rentabilité Ebitda, % 117 10
Rentabilité EPS, % 45.6 6
Total: 7.2
Plus de détails

Date de transaction Date de divulgation Insider Taper Prix Volume Quantité Partagez jusqu'à, % Partager après, % Document
25.09.2024 26.09.2024 Mulligan Richard
Director		 Vente 3.89 583 500 150000 0 -0.08 lien
24.09.2024 26.09.2024 Mulligan Richard
Director		 Vente 4.08 612 000 150000 0 -0.08 lien
07.06.2023 08.06.2023 Flagship Ventures Fund V Gener
10% Owner		 Vente 6.24 1 248 000 200000 0 -0.11 lien
06.06.2023 08.06.2023 Flagship Ventures Fund V Gener
10% Owner		 Vente 6.31 1 285 710 203758 0 -0.11 lien
26.05.2023 26.05.2023 Flagship Ventures Fund V Gener
10% Owner		 Vente 6.23 510 860 82000 0 -0.04 lien
25.05.2023 26.05.2023 Flagship Ventures Fund V Gener
10% Owner		 Vente 6.35 732 612 115372 0 -0.06 lien
24.05.2023 26.05.2023 Flagship Ventures Fund V Gener
10% Owner		 Vente 6.57 2 285 510 347870 0 -0.18 lien
21.03.2022 22.03.2022 Yang Patrick Y
Director		 Achat 7.3 204 400 28000 0 0.01 lien
09.09.2021 10.09.2021 Hordo Christian
EVP, Chief Business Officer		 Vente 25.01 1 617 420 64671 0 -0.03 lien
03.09.2021 07.09.2021 Hordo Christian
EVP, Chief Business Officer		 Vente 25 17 500 700 0 0 lien
03.09.2021 07.09.2021 Hordo Christian
EVP, Chief Business Officer		 Achat 1.48 1 036 700 0 0 lien
02.09.2021 07.09.2021 Hordo Christian
EVP, Chief Business Officer		 Vente 25 198 950 7958 0 0 lien
02.09.2021 07.09.2021 Hordo Christian
EVP, Chief Business Officer		 Achat 1.48 9 706 6558 0 0 lien

Établissements Volume Partager, %
Flagship Pioneering Inc. 25001856 11.34
FMR, LLC 15751291 7.15
Canada Pension Plan Investment Board 10175000 4.62
Baillie Gifford and Company 10150017 4.6
Vanguard Group Inc 9797084 4.44
Blackrock Inc. 8469222 3.84
State Street Corporation 5908687 2.68
Price (T.Rowe) Associates Inc 3594025 1.63
Crestline Management, L.P. 3365624 1.53
Alphabet Inc. 2812500 1.28

ETF Partager, % Rentabilité pour l'année, % Dividendes, %
Avantis U.S. Equity ETF 0.00014 37.016870113839 1.59151
Virtus LifeSci Biotech Clinical Trials ETF 0.47073 77.329244365683 0.33
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.03662 37.61291904149 1.59225
ProShares Ultra Nasdaq Biotechnology 0.06315 58.954326923077 0.85651
Dimensional U.S. Core Equity 2 ETF 0.00322 37.528779739064 1.47098
Dimensional US Core Equity Market ETF 0.0017 35.65815324165 1.40618
Dimensional U.S. Equity ETF 0.00085 36.134982184029 1.3557
Vanguard ESG U.S. Stock ETF 0 37.253765932793 1.26927
Fidelity MSCI Health Care Index ETF 0.00868 21.181088923024 1.46057
Goldman Sachs Innovate Equity ETF 0.05881 36.115879828326 1.20987
Global X Genomics & Biotechnology ETF 0.94439 14.095744680851 0.15585
ProShares Hedge Replication ETF 0.00346 6.8665973306333 1.47892
Humankind US Stock ETF 0.00834 22.971795629061 1.99919
Invesco Nasdaq Biotechnology ETF 0.09864 29.399255715045 0.8565
iShares Morningstar Small-Cap ETF 0.01096 37.681332167863 1.60498
iShares Morningstar Small-Cap Growth ETF 0.01678 41.553945249597 0.72598
iShares Morningstar Small Cap Value ETF 0.00549 40.493824576094 2.50476
iShares Russell 2000 Growth ETF 0.04172 47.42032299557 0.6026
iShares Russell 3000 ETF 0.0014 37.942616648456 1.43482
iShares Morningstar Small-Cap ETF 0.01096 410.50632631881 1.60498
iShares Morningstar Small-Cap Growth ETF 0.01678 757.51743375174 0.72598
iShares Morningstar Small-Cap Value ETF 0.00549 252.86210418795 2.50476
Direxion Daily S&P Biotech Bull 3x Shares 0.12306 5201.8382352941 0.25924
Schwab U.S. Small-Cap ETF 0.01263 -30.367553865653 1.51433
Schwab U.S. Broad Market ETF 0.00087 -53.970149253731 1.43354
SPDR Portfolio MSCI Global Stock Market ETF 0.00328 29.55850326668 2.19607
FlexShares Morningstar US Market Factor Tilt Index Fund 0.00326 37.307074947524 1.69572
ProShares UltraPro Russell2000 0.01214 125.96465921385 1.47873
Vanguard U.S. Momentum Factor ETF 0.06 52.778724259342 1.05834
Vanguard Russell 3000 ETF 0 38.467141890837 1.43817
Vanguard Russell 2000 Growth ETF 0.06 46.764050831914 0.60264
Vanguard Russell 2000 ETF 0.03 41.410408042578 1.48801
WisdomTree BioRevolution Fund 0.44668 20.081421169504 0.78691
Principal Healthcare Innovators ETF 0.0919 631.79771324797 0.8416
Future Tech ETF 0.0919 412.888593871 0.8416



Superviseur Titre d'emploi Paiement Année de naissance
Mr. Nathan Hardy M.B.A. Executive VP & CFO 683.49k 1976 (48 années)
Dr. Edward Rebar Ph.D. Head of Cell Engineering N/A 1968 (56 années)
Ms. Robin Andrulevich Executive VP & Chief People Officer N/A 1966 (58 années)
Dr. Steven D. Harr M.D. President, CEO & Director 1.04M 1970 (54 année)
Mr. Paul Brunetta M.D. Senior VP and Head of Clinical & Translational Science N/A
Mr. Bernard J. Cassidy J.D. Executive VP, General Counsel & Corporate Secretary 491.39k 1955 (69 années)
Mr. Christian Hordo M.B.A. Executive VP & Chief Business Officer 485.03k 1983 (41 année)
Dr. Sonja Schrepfer M.D., Ph.D. Senior VP & Head of Hypoimmune Platform N/A 1975 (49 années)
Mr. Snehal Patel Senior VP & Chief Technical Officer
Dr. Dhavalkumar D. Patel M.D., Ph.D. Executive VP & Chief Scientific Officer 1961 (63 année)

Adresse: United States, Seattle, WA , 188 East Blaine Street - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.sana.com